These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 19575173)
1. Elevated circulating levels of matrix metalloproteinases MMP-2 and MMP-9 in pseudoxanthoma elasticum patients. Diekmann U; Zarbock R; Hendig D; Szliska C; Kleesiek K; Götting C J Mol Med (Berl); 2009 Oct; 87(10):965-70. PubMed ID: 19575173 [TBL] [Abstract][Full Text] [Related]
2. Analysis of MMP2 promoter polymorphisms in patients with pseudoxanthoma elasticum. Zarbock R; Hendig D; Szliska C; Kleesiek K; Götting C Clin Chim Acta; 2010 Oct; 411(19-20):1487-90. PubMed ID: 20541540 [TBL] [Abstract][Full Text] [Related]
3. Matrix Metalloproteinases Contribute to the Calcification Phenotype in Pseudoxanthoma Elasticum. Plümers R; Lindenkamp C; Osterhage MR; Knabbe C; Hendig D Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189419 [TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of intercellular adhesion molecule ICAM-1 in Pseudoxanthoma elasticum. Hendig D; Adam A; Zarbock R; Szliska C; Kleesiek K; Götting C Clin Chim Acta; 2008 Aug; 394(1-2):54-8. PubMed ID: 18440309 [TBL] [Abstract][Full Text] [Related]
5. Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Hendig D; Schulz V; Arndt M; Szliska C; Kleesiek K; Götting C Clin Chem; 2006 Feb; 52(2):227-34. PubMed ID: 16384891 [TBL] [Abstract][Full Text] [Related]
6. Elevated xylosyltransferase I activities in pseudoxanthoma elasticum (PXE) patients as a marker of stimulated proteoglycan biosynthesis. Götting C; Hendig D; Adam A; Schön S; Schulz V; Szliska C; Kuhn J; Kleesiek K J Mol Med (Berl); 2005 Dec; 83(12):984-92. PubMed ID: 16133423 [TBL] [Abstract][Full Text] [Related]
7. Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum. Dabisch-Ruthe M; Kuzaj P; Götting C; Knabbe C; Hendig D J Dermatol Sci; 2014 Aug; 75(2):109-20. PubMed ID: 24907773 [TBL] [Abstract][Full Text] [Related]
11. Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Gorgels TG; Hu X; Scheffer GL; van der Wal AC; Toonstra J; de Jong PT; van Kuppevelt TH; Levelt CN; de Wolf A; Loves WJ; Scheper RJ; Peek R; Bergen AA Hum Mol Genet; 2005 Jul; 14(13):1763-73. PubMed ID: 15888484 [TBL] [Abstract][Full Text] [Related]
12. [From gene to disease; pseudoxanthoma elasticum and the ABCC6 gene]. Bergen AA; Plomp AS; Gorgels TG; de Jong PT Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1586-9. PubMed ID: 15382558 [TBL] [Abstract][Full Text] [Related]
13. Novel mutations in the ABCC6 gene of German patients with pseudoxanthoma elasticum. Schulz V; Hendig D; Szliska C; Götting C; Kleesiek K Hum Biol; 2005 Jun; 77(3):367-84. PubMed ID: 16392638 [TBL] [Abstract][Full Text] [Related]
14. Circulating P-, L- and E-selectins in pseudoxanthoma elasticum patients. Götting C; Adam A; Szliska C; Kleesiek K Clin Biochem; 2008 Apr; 41(6):368-74. PubMed ID: 18191640 [TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the ABCC6 gene and the proximal ABCC6 gene promoter in German patients with pseudoxanthoma elasticum (PXE). Schulz V; Hendig D; Henjakovic M; Szliska C; Kleesiek K; Götting C Hum Mutat; 2006 Aug; 27(8):831. PubMed ID: 16835894 [TBL] [Abstract][Full Text] [Related]
16. Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro. Le Saux O; Bunda S; VanWart CM; Douet V; Got L; Martin L; Hinek A J Invest Dermatol; 2006 Jul; 126(7):1497-505. PubMed ID: 16543900 [TBL] [Abstract][Full Text] [Related]
17. Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. Chassaing N; Martin L; Calvas P; Le Bert M; Hovnanian A J Med Genet; 2005 Dec; 42(12):881-92. PubMed ID: 15894595 [TBL] [Abstract][Full Text] [Related]